PHOENIX BIOTECH ACQUISITION CORP. Stock Agreements
9 Contracts & Agreements
- Common Stock Purchase Agreement, by and between CERo Therapeutics Holdings, Inc., and an institutional investor, dated as of November 8, 2024 (Filed With SEC on November 12, 2024)
- Common Stock Purchase Agreement, dated as of February 14, 2024, by and between CERo Therapeutics Holdings, Inc. and the Lead Investor (Filed With SEC on February 27, 2024)
- CERo Therapeutics Holdings, Inc. 2024 Employee Stock Purchase Plan (Filed With SEC on February 27, 2024)
- Amendment No. 1 to the Investment Management Trust Agreement, dated December 20, 2022, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (Filed With SEC on December 20, 2022)
- Investment Management Trust Agreement, dated October 5, 2021, between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on October 12, 2021)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on September 21, 2021)
- Specimen Common Stock Certificate (Filed With SEC on September 21, 2021)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on September 13, 2021)
- Specimen Common Stock Certificate (Filed With SEC on September 13, 2021)
